Xeomin

Also known as: IncobotulinumtoxinA, Botulinum toxin type A, Neuromodulator, Anti-wrinkle injection

Neurotoxins & Dermal Fillers

AI Aesthetician Summary

Xeomin (incobotulinumtoxinA) is a purified botulinum toxin type A neuromodulator manufactured by Merz Pharmaceuticals that represents a unique approach to aesthetic and therapeutic treatments. This injectable medication is distinguished by its formulation, which lacks the accessory proteins found in...

Treatment Details

Targets

Concerns:Frown Lines Crow's Feet Wrinkles Neck Wrinkles Sweaty Armpits Sweaty Palms

Areas:Forehead, Eye, Jaw, Neck

Tissues:Muscle/SMAS, Skin (Epidermis, Dermis)

Longevity:3-6 Months

How it Works

Duration:15 minutes

Anesthesia:Topical (e.g., Numbing Cream)

Pain Level:Mild

Techniques:Injection

Session Notes:Treatment generally takes 10–20 minutes; onset of effect begins within a few days with maximum results by two weeks and duration around 3–6 months. Review medical history for neuromuscular disorders, pregnancy, or breastfeeding, and tailor dosing to treatment areas. Discuss expectations and potential need for repeat maintenance treatments.

Post Treatment

Downtime:0 days

Risks:Possible risks include bruising, swelling, or pain at injection sites, temporary localized weakness or asymmetry (including eyelid droop), headache, flu-like symptoms, and rare allergic reactions. Incorrect placement can cause unwanted muscle weakness or changes in facial expression.

Additional Information

Invasiveness:Minimally Invasive

Manufacturer:Merz Aesthetics

Specialty:Medical Spa

Research